Impaired Neutralization of SARS-CoV-2 Including Omicron Variants after COVID-19 mRNA Booster Immunization under Methotrexate Therapy
View ORCID ProfileElisa Habermann, View ORCID ProfileLutz Gieselmann, View ORCID ProfilePinkus Tober-Lau, View ORCID ProfileAlexander ten Hagen, View ORCID ProfileFredrik N Albach, View ORCID ProfileJan Zernicke, Elvin Ahmadov, View ORCID ProfileAmanthi Nadira Arumahandi de Silva, View ORCID ProfileLeonie Maria Frommert, View ORCID ProfileJens Klotsche, View ORCID ProfileFlorian Kurth, View ORCID ProfileLeif Erik Sander, View ORCID ProfileGerd Burmester, View ORCID ProfileFlorian Klein, View ORCID ProfileRobert Biesen
doi: https://doi.org/10.1101/2022.06.11.22276272
Elisa Habermann
1Department of Rheumatology and Clinical Immunology, Charité – Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
Lutz Gieselmann
2Laboratory of Experimental Immunology, Institute of Virology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany
Pinkus Tober-Lau
3Department of Infectious Diseases and Respiratory Medicine, Charité – Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
Alexander ten Hagen
1Department of Rheumatology and Clinical Immunology, Charité – Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
Fredrik N Albach
1Department of Rheumatology and Clinical Immunology, Charité – Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
Jan Zernicke
1Department of Rheumatology and Clinical Immunology, Charité – Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
Elvin Ahmadov
2Laboratory of Experimental Immunology, Institute of Virology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany
Amanthi Nadira Arumahandi de Silva
1Department of Rheumatology and Clinical Immunology, Charité – Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
Leonie Maria Frommert
1Department of Rheumatology and Clinical Immunology, Charité – Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
Jens Klotsche
2Laboratory of Experimental Immunology, Institute of Virology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany
Florian Kurth
3Department of Infectious Diseases and Respiratory Medicine, Charité – Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
Leif Erik Sander
3Department of Infectious Diseases and Respiratory Medicine, Charité – Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
Gerd Burmester
1Department of Rheumatology and Clinical Immunology, Charité – Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
Florian Klein
2Laboratory of Experimental Immunology, Institute of Virology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany
5German Center for Infection Research, Partner site Bonn-Cologne, Cologne, Germany
6Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany
Robert Biesen
1Department of Rheumatology and Clinical Immunology, Charité – Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Data Availability
All data relevant to the study are included in the article. Data are available on reasonable request.
Posted June 14, 2022.
Impaired Neutralization of SARS-CoV-2 Including Omicron Variants after COVID-19 mRNA Booster Immunization under Methotrexate Therapy
Elisa Habermann, Lutz Gieselmann, Pinkus Tober-Lau, Alexander ten Hagen, Fredrik N Albach, Jan Zernicke, Elvin Ahmadov, Amanthi Nadira Arumahandi de Silva, Leonie Maria Frommert, Jens Klotsche, Florian Kurth, Leif Erik Sander, Gerd Burmester, Florian Klein, Robert Biesen
medRxiv 2022.06.11.22276272; doi: https://doi.org/10.1101/2022.06.11.22276272
Impaired Neutralization of SARS-CoV-2 Including Omicron Variants after COVID-19 mRNA Booster Immunization under Methotrexate Therapy
Elisa Habermann, Lutz Gieselmann, Pinkus Tober-Lau, Alexander ten Hagen, Fredrik N Albach, Jan Zernicke, Elvin Ahmadov, Amanthi Nadira Arumahandi de Silva, Leonie Maria Frommert, Jens Klotsche, Florian Kurth, Leif Erik Sander, Gerd Burmester, Florian Klein, Robert Biesen
medRxiv 2022.06.11.22276272; doi: https://doi.org/10.1101/2022.06.11.22276272
Subject Area
Subject Areas
- Addiction Medicine (349)
- Allergy and Immunology (671)
- Anesthesia (181)
- Cardiovascular Medicine (2660)
- Dermatology (224)
- Emergency Medicine (401)
- Epidemiology (12261)
- Forensic Medicine (10)
- Gastroenterology (765)
- Genetic and Genomic Medicine (4122)
- Geriatric Medicine (387)
- Health Economics (681)
- Health Informatics (2668)
- Health Policy (1007)
- Hematology (364)
- HIV/AIDS (855)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (440)
- Neurology (3909)
- Nursing (210)
- Nutrition (581)
- Oncology (2043)
- Ophthalmology (587)
- Orthopedics (242)
- Otolaryngology (306)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1116)
- Primary Care Research (453)
- Public and Global Health (6548)
- Radiology and Imaging (1407)
- Respiratory Medicine (871)
- Rheumatology (411)
- Sports Medicine (343)
- Surgery (452)
- Toxicology (54)
- Transplantation (186)
- Urology (167)